+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery



Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery



Angewandte Chemie 53(23): 5815-5820



A liposome-based co-delivery system composed of a fusogenic liposome encapsulating ATP-responsive elements with chemotherapeutics and a liposome containing ATP was developed for ATP-mediated drug release triggered by liposomal fusion. The fusogenic liposome had a protein-DNA complex core containing an ATP-responsive DNA scaffold with doxorubicin (DOX) and could release DOX through a conformational change from the duplex to the aptamer/ATP complex in the presence of ATP. A cell-penetrating peptide-modified fusogenic liposomal membrane was coated on the core, which had an acid-triggered fusogenic potential with the ATP-loaded liposomes or endosomes/lysosomes. Directly delivering extrinsic liposomal ATP promoted the drug release from the fusogenic liposome in the acidic intracellular compartments upon a pH-sensitive membrane fusion and anticancer efficacy was enhanced both in vitro and in vivo.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982063

Download citation: RISBibTeXText

PMID: 24764317

DOI: 10.1002/anie.201400268


Related references

Cationic liposomal co-delivery of small interfering RNA and a MEK inhibitor for enhanced anticancer efficacy. Pharmaceutical Research 28(12): 3069-3078, 2012

Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system. Nanoscale 7(9): 4088-4096, 2016

Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems. Nanomaterials 7(11), 2017

Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy. Journal of Oncology 2010: 723798-723798, 2010

Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy. Plos One 9(8): E102727-E102727, 2015

Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models. Plos One 8(12): E83239-E83239, 2014

Polyphosphazene vesicles for co-delivery of doxorubicin and chloroquine with enhanced anticancer efficacy by drug resistance reversal. International Journal of Pharmaceutics 498(1-2): 70-81, 2016

Fabrication of Thermosensitive Cyclic Brush Copolymer with Enhanced Therapeutic Efficacy for Anticancer Drug Delivery. Macromolecular Rapid Communications, 2018

Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Molecular Cancer Therapeutics 8(7): 1955-1963, 2009

Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules 23(4), 2018

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery. International Journal of Nanomedicine 12: 8557-8572, 2017

Liposomal temozolomide drug delivery using convection enhanced delivery. Journal of Controlled Release 261: 138-146, 2017

In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. Journal of Controlled Release 114(2): 153-162, 2006

Cell penetrating peptide amphiphile integrated liposomal systems for enhanced delivery of anticancer drugs to tumor cells. Faraday Discussions 166: 269-283, 2014

The human biomolecular corona of liposomal doxorubicin: The overlooked factor in anticancer drug delivery. Acs Applied Materials & Interfaces, 2018